Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-TCR-T cells for CMV infection after HSCT
NCT05140187Phase 1Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2021
- Primary completion
- Dec 2024
- Modality
- TCR-Engineered T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of CMV-TCR-T cells in cytomegalovirus infection (CMV), sponsored by Chinese PLA General Hospital. Primary endpoint: Adverse events at 1 year. Status: unknown.
02
Drugs
CMV-TCR-T cells
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT05140187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140187.